anti-CD96 agonist antibody(Talix Therapeutics NV)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Nameanti-CD96 agonist antibody(Talix Therapeutics NV)

Drug Alias NameBL006-4-20CD96 costimulator (cancer), Talix Therapeutics/ Samyanganti-CD96 agonist antibody (cancer), Talix Therapeutics/Samyang CorpBL006-4-20

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionT-cell surface protein tactile agonistsImmunostimulants

TargetsT-cell surface protein tactile

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSamyang Corp

China Registration ClassN/A

Develop Information

Active CompaniesSamyang Corp

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A